Diabetic foot infections: Microbiology made modern? Array of hope

Diabetes Care

Volumn 30, Issue 8, 2007, Pages 2171-2172

  Lipsky, Benjamin A ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; STAPHYLOCOCCUS ENTEROTOXIN; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM ISOLATE; DIABETIC FOOT; DISEASE SEVERITY; EDITORIAL; ENTEROCOCCUS; FOOT ULCER; HUMAN; INCIDENCE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; WOUND HEALING; WOUND INFECTION;

ANTI-BACTERIAL AGENTS; DIABETIC FOOT; DRUG RESISTANCE, BACTERIAL; HUMANS; STAPHYLOCOCCAL INFECTIONS;

EID: 34547697713     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-0935     Document Type: Editorial

References (23)

1. Lipsky BA: A report from the international consensus on diagnosing and treating the infected diabetic foot. Diabet Metab Res Rev 20 (Suppl. 1):S68-S77, 2004
2. Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, LeFrock JL, Lew DP, Mader JT, Norden C, Tan JS, Infectious Diseases Society of America: Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 39:885-910, 2004
3. Societe de Pathologie Infectieuse de Langue Francaise: [Management of diabetic foot infections: short text[. Med Mal Infect 37:1-25, 2007 [article in French]
4. Lipsky BA: Empirical therapy for diabetic foot infections: are there clinical clues to guide antibiotic selection? Clin Microbiol Infect 13:351-353, 2007
5. Eady EA, Cove JH: Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus: an emerging problem for the management of skin and soft tissue infections. Curr Opin Infect Dis 16:103-124, 2003
6. Dang CN, Prasad YD, Boulton AJ, Jude EB: Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med 20:159-161, 2003
7. Tascini C, Gemignani G, Palumbo F, Leonildi A, Tedeschi A, Lambelet P, Lucarini A, Piaggesi A, Menichetti F: Clinical and microbiological efficacy of colistin therapy alone or in combination as treatment for multidrug resistant Pseudomonas aeruginosa diabetic foot infections with or without osteomyelitis. J Chemother 18:648-651, 2006
8. Viswanathan V: The diabetic foot: perspectives from Chennai, South India. Int J Low Extrem Wounds 6:34-36, 2007
9. Shankar EM, Mohan V, Premalatha G, Srinivasan RS, Usha AR: Bacterial etiology of diabetic foot infections in South India. Eur J Intern Med 16:567-570, 2005
10. Lipsky BA, Armstrong DG, Citron DM, Tice AD, Morgenstern DE, Abramson MA: Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. Lancet 366:1695-1703, 2005
11. Edmonds M: Infection in the neuroischemic foot. Int J Low Extrem Wounds 4:145-153, 2005
12. Sotto A, Richard J-L, Jourdan N, Combescure C, Bouziges N, Lavigne J-P, Nîmes University Hospital Working Group on the Diabetic Foot (GP30): Miniaturized oligonucleotide arrays: a new tool for discriminating colonization from infection due to Staphylococcus aureus in diabetic foot ulcers. Diabetes Care 30:XXXX-XXXX, 2007
13. Lavery LA, Armstrong DG, Murdoch DP, Peters EJ, Lipsky BA: Validation of the Infectious Diseases Society of America's diabetic foot infection classification system. Clin Infect Dis 44:562-565, 2007
14. Heller MJ: DNA microarray technology: devices, systems, and applications. Annu Rev Biomed Eng 4:129-153, 2002
15. Lipsky BA, Sheehan P, Armstrong DG, Tice AD, Polis AB, Abramson MA: Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial. Int Wound J 4:30-38, 2007
16. Tentolouris N, Petrikkos G, Vallianou N, Zachos C, Daikos GL, Tsapogas P, Markou G, Katsilambros N: Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers. Clin Microbiol Infect 12:186-189, 2006
17. Wagner A, Reike H, Angelkort B: [Highly resistant pathogens in patients with diabetic foot syndrome with special reference to methicillin-resistant Staphylococcus aureus infections.] Dtsch Med Wochenschr 126:1353-1356, 2001 [article in German]
18. Monecke S, Slickers P, Hotzel H, Richter-Huhn G, Pohle M, Weber S, Witte W, Ehricht R: Microarray-based characterisation of a Panton-Valentine leukocidinpositive community-acquired strain of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 12:718-728, 2006
19. Monecke S, Ehricht R: Rapid genotyping of methicillin-resistant Staphylococcus aureus (MRSA) isolates using miniaturised oligonucleotide arrays. Clin Microbiol Infect 11:825-833, 2005
20. Horii T, Morita M, Muramatsu H, Monji A, Miyagishima D, Kanno T, Maekawa M: Antibiotic resistance in aeromonas hydrophila and vibrio alginolyticus isolated from a wound infection: a case report. J Trauma 58:196-200, 2005
21. Akbulut D, Grant KA, McLauchlin J: Improvement in laboratory diagnosis of wound botulism and tetanus among injecting illicit-drug users by use of realtime PCR assays for neurotoxin gene fragments. J Clin Microbiol 43:4342-4348, 2005
22. Rosche TM, Yano Y, Oliver JD: A rapid and simple PCR analysis indicates there are two subgroups of Vibrio vulnificus which correlate with clinical or environmental isolation. Microbiol Immunol 49:381-389, 2005
23. Phillips R, Horsfield C, Kuijper S, Lartey A, Tetteh I, Etuaful S, Nyamekye B, Awuah P, Nyarko KM, Osei-Sarpong F, Lucas S, Kolk AH, Wansbrough-Jones M: Sensitivity of PCR targeting the IS2404 insertion sequence of Mycobacterium ulcerans in an assay using punch biopsy specimens for diagnosis of Buruli ulcer. J Clin Microbiol 43:3650-3656, 2005